These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5125767)

  • 1. Crystal structure of a 1:1 aminopyrine-barbital complex.
    Kiryu S
    J Pharm Sci; 1971 May; 60(5):699-703. PubMed ID: 5125767
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct preparation of solid particulates of aminopyrine-barbital complex (pyrabital) from droplets by a spray-drying technique.
    Kawashima Y; Lin SY; Ueda M; Takenaka H; Ando Y
    J Pharm Sci; 1983 May; 72(5):514-8. PubMed ID: 6864497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raman spectra and structure of molecular addition compound of aminopyrine and barbital in aqueous solution].
    KASHIMA T; WATARI T; MIKUBO H
    Eisei Shikenjo Hokoku; 1961 Sep; 79():59-63. PubMed ID: 14454136
    [No Abstract]   [Full Text] [Related]  

  • 4. Crystal structure of a 1:1 aminopyrine-cyclobarbital complex.
    Kiryu S; Hirayama F; Iguchi S
    Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1588-92. PubMed ID: 4434581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the phase diagram of aminopyrine-barbital-water system and crystal data of the molecular compound of aminopyrine and barbital].
    Kiryu S; Iguchi S
    Yakugaku Zasshi; 1969 May; 89(5):707-11. PubMed ID: 5818008
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979; 34(3):164-7. PubMed ID: 450956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physico-chemical studies of alloy of 4-dimethylamino-2,3-dimethyl-1-phenylpyrazolinone-5 with 5,5-diethylbarbituric acid, entering into composition of pharmaceutical preparations].
    Wiśniewski W; Szlaski J; Furmańczyk Z
    Acta Pol Pharm; 1969; 26(5):443-5. PubMed ID: 5356249
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystal structure of 1:1 complex of barbital with 1-methylimidazole.
    Wang A; Craven BM
    J Pharm Sci; 1979 Mar; 68(3):361-3. PubMed ID: 423128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the polymorphism of barbiturates in powders and tablets. Part 2: On the infrared spectroscopy and the X-ray diffractometry of barbital (author's transl)].
    Hollenbach K; Mezösi J; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1979 Apr; 34(4):240-2. PubMed ID: 482331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular association of barbital and caffeine in 2:1 crystalline complex.
    Craven BM; Gartland GL
    J Pharm Sci; 1970 Nov; 59(11):1666-70. PubMed ID: 5495500
    [No Abstract]   [Full Text] [Related]  

  • 12. The crystal structures of two polymorphs of 5,5'-diethylbarbituric acid (barbital).
    Craven BM; Vizzini EA; Rodrigues MM
    Acta Crystallogr B Struct Crystallogr Cryst Chem; 1969 Oct; 25(10):1978-93. PubMed ID: 5394972
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the polymorphism of barbital.
    Grabowska I; Kaliszan R
    Pol J Pharmacol Pharm; 1976; 28(5):529-36. PubMed ID: 1012979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of complex formation on interfacial transfer rate of drugs across two liquid phases (author's transl)].
    Kiryu S; Tateyama T; Iguchi S
    Yakugaku Zasshi; 1982 Jan; 102(2):207-10. PubMed ID: 7108751
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative action of barbital and of barbital associated with amibophenazone on respiratory function in the rabbit].
    Carminati GM; Spina G
    Boll Chim Farm; 1965 May; 104(5):309-16. PubMed ID: 5826889
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of combination of pharmaceuticals on gastrointestinal absorption. 3. Combination of aminopyrine and barbital.
    Goto S; Tsuzuki O; Iguchi S
    Chem Pharm Bull (Tokyo); 1971 May; 19(5):944-53. PubMed ID: 5557931
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between enhancement of plasma level of aminopyrine by barbital and stomach emptying pattern.
    Goto S; Tsuzuki O; Iguchi S
    J Pharm Sci; 1972 Jun; 61(6):945-7. PubMed ID: 5046117
    [No Abstract]   [Full Text] [Related]  

  • 18. Cycloheptaamylose inclusion complexes of barbiturates: correlation between proton magnetic resonance and solubility studies.
    Thakkar AL; Demarco PV
    J Pharm Sci; 1971 Apr; 60(4):652-3. PubMed ID: 5128390
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative action of barbital and of barbital associated with aminophenazone on basal metabolism and on mortality rate in the rat].
    Carminati GM; Spina G
    Boll Chim Farm; 1965 May; 104(5):317-22. PubMed ID: 5826890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Crystalline structure of the molecular complex 1-3 aminophenazone-thiourea].
    Terol A; Chauvet A; De Maury G; Masse J
    Farmaco Prat; 1987 Jan; 42(1):3-16. PubMed ID: 3104079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.